ANIP ANI PHARMACEUTICALS INC: institutional ownership and insider trading
319 funds reported holding $2.03B of ANI PHARMACEUTICALS INC in their latest 13F filings; in Q2 2026 funds net sold $66.0M, with 49 new positions and 24 funds selling out; over the last 12 months insiders bought $0 and sold $15.5M on the open market.
Famous investors holding ANIP
- Izzy Englander (Millennium Management): $42.0M, 0.0% of the portfolio
- D. E. Shaw (D. E. Shaw & Co.): $14.5M, 0.0% of the portfolio
- Renaissance Technologies (Renaissance Technologies): $5.27M, 0.0% of the portfolio
- Ken Griffin (Citadel Advisors): $8.67M, 0.0% of the portfolio
- Two Sigma (Two Sigma Investments): $5.32M, 0.0% of the portfolio
Largest institutional holders of ANIP
- BlackRock, Inc. (BLK) — $245M
- VANGUARD GROUP INC — $103M
- Soleus Capital Management, L.P. — $71.8M
- VANGUARD CAPITAL MANAGEMENT LLC — $69.4M
- STATE STREET CORP (STT, STT-PG) — $68.9M
- TANG CAPITAL MANAGEMENT LLC — $58.6M
- DIMENSIONAL FUND ADVISORS LP — $51.6M
- AMERICAN CENTURY COMPANIES INC — $47.6M
- ARROWSTREET CAPITAL, LIMITED PARTNERSHIP — $46.5M
- Global Alpha Capital Management Ltd. — $46.2M
Recent ANIP insider trades
- Oct 15, 2026: Lalwani Nikhil sold 5,400 shares ($388K)
- Oct 13, 2026: Cook Meredith sold 500 shares ($36.8K)
- Sep 29, 2026: Carey Stephen P. sold 2,850 shares ($208K)
- Sep 15, 2026: Lalwani Nikhil sold 5,400 shares ($383K)
5%+ owners
- BlackRock, Inc.: 12.8% (Schedule 13G/A, filed Jul 27, 2026)